GG 957 (Methylprednisolone 4 mg)

Pill imprint GG 957 has been identified as Methylprednisolone 4 mg.

Methylprednisolone is used in the treatment of inflammatory conditions; gout, acute; allergic rhinitis; atopic dermatitis; asthma, acute (and more), and belongs to the drug class glucocorticoids. Excluding first trimester: Risk cannot be ruled out during pregnancy. First trimester: There is positive evidence of human fetal risk during pregnancy. Methylprednisolone 4 mg is not a controlled substance under the Controlled Substance Act (CSA).

Methylprednisolone

Imprint:

GG 957

Strength:

4 mg

Color:

White

Size:

8.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Glucocorticoids

Pregnancy Category:

C - Risk cannot be ruled out - excluding first trimester
D - Positive evidence of risk - first trimester

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Pharmaceuticals Inc.

National Drug Code (NDC):

00781-5022

Inactive Ingredients:

lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
66267-0961	Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.